Topic
The UAE approved Foundayo, Eli Lilly's oral obesity pill (orforglipron), on 3 April 2026 — two days after FDA approval. Abu Dhabi's Department of Health added it to its Personalised Weight Management Programme, making the UAE the second country in the world to offer this
28 Apr 2026